Effect of AmBisome on Chagas Disease in Mice
Author Information
Author(s): Cencig Sabrina, Coltel Nicolas, Truyens Carine, Carlier Yves
Primary Institution: Laboratoire de Parasitologie, Faculté de Médecine, Université Libre de Bruxelles, Brussels, Belgium
Hypothesis
Does AmBisome treatment reduce parasitic loads and improve survival in mice infected with Trypanosoma cruzi?
Conclusion
AmBisome treatment significantly reduces parasitic loads in tissues and prevents mortality in mice infected with T. cruzi, but does not completely cure the infection.
Supporting Evidence
- AmBisome treatment during the acute phase prevented mortality in infected mice.
- Parasite loads were significantly reduced in heart, liver, spleen, skeletal muscle, and adipose tissues.
- Earlier administration of AmBisome was more effective in reducing parasite loads.
Takeaway
Researchers gave a medicine called AmBisome to sick mice to see if it helps them get better from a parasite. It helped the mice live longer and made the germs in their bodies much less.
Methodology
Mice were infected with T. cruzi and treated with AmBisome in various phases of infection; parasitic loads were measured using quantitative PCR.
Potential Biases
Potential bias in treatment administration and measurement of outcomes.
Limitations
The study does not demonstrate complete cure of T. cruzi infection in treated mice.
Participant Demographics
BALB/cJ mice, 6 weeks old, infected with T. cruzi.
Statistical Information
P-Value
0.0003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website